While a pause on federal health agencies is nothing new during presidential transitions, the Trump Administration’s ...
The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.
Recent federal developments may soon require cosmetic companies to adopt stringent precautions to ensure that talc-containing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results